At a glance
ClinicalIndex Comparison RecordN/ACompleted· 150 target
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Importance of Exogenous Reinfection in the Tuberculosis Endemic of Taiwan
In Brief
An observational study for Tuberculosis. Completed, enrolled 150 participants across 1 site.
Detailed Summary
we hypothesize that exogenous reinfection is very important in the Taiwan endemic. Therefore, we design a series of studies to evaluate the individual contribution of exogenous reinfection and endogenous reactivation in the Taiwan endemic, and to realize the impact of exogenous reinfection. First, we will identify the patients with TB relapse after complete treatment. The M. tuberculosis isolates responsible for their initial and recurrent episodes will then be genotyped to clarify the percentage of exogenous reinfection and endogenous reinfection.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsTuberculosis
CountriesTaiwan
Collaborators--
Timeline
N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartAug 2005
First PostedSep 2005
Primary CompletionJul 2006
TodayJul 2026
First PostedSep 15, 2005
Enrollment StartAug 1, 2005
Primary CompletionJul 1, 2006
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 20.8 years ago